Gagnon Securities’s Standard BioTools LAB Stock Holding History

Gagnon Securities’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-24,677	Closed	-$26.7K	–	92
2025 Q1	$26.7K	Buy	24,677 +747	+3%	+$1.05K	0.01%	98
2024 Q4	$41.9K	Sell	23,930 -36,494	-60%	-$68K	0.01%	91
2024 Q3	$117K	Sell	60,424 -838,085	-93%	-$1.64M	0.02%	97
2024 Q2	$1.59M	Buy	898,509 +43,364	+5%	+$106K	0.36%	46
2024 Q1	$2.32M	Buy	+855,145	New	+$2.06M	0.55%	40

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Gagnon Securities's LAB Position: Q2 2025 in Review

Gagnon Securities sold out of Standard BioTools (LAB) in Q2 2025, closing a stake of 24,677 shares — an estimated $26.7K sold.

Gagnon Securities first reported a position in LAB in Q1 2024 and held it in 5 quarters. The position peaked at $2.32M in Q1 2024. 160 funds tracked by Wall St. Rank hold LAB as of Q2 2025.

Gagnon Securities reported no remaining Standard BioTools position as of Q2 2025 after selling out during the quarter.
Gagnon Securities sold 24,677 Standard BioTools shares in Q2 2025, an estimated $26.7K.
Gagnon Securities first reported a position in Standard BioTools in Q1 2024 and held it in 5 quarters.
Gagnon Securities's Standard BioTools position peaked at $2.32M in Q1 2024.
160 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2025.

Based on Gagnon Securities's 13F filing for Q2 2025, filed 23 Jul 2025.